Argent Biopharma Ltd Long-term Investment Intensity
Argent Biopharma Ltd long-term investment intensity. Argent Biopharma Ltd (RGT) has a Long-term Investment Intensity of 12.3% as of June 2024. Long-term investments of AU$1.33 Million represent 12.3% of total assets of AU$10.79 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Argent Biopharma Ltd total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Argent Biopharma Ltd (2018–2024)
Long-term investment intensity of Argent Biopharma Ltd from 2018 to 2024. This chart shows how Argent Biopharma Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2018 to 2024. As of June 2024, the intensity stands at 12.3%, reflecting long-term investments of AU$1.33 Million against total assets of AU$10.79 Million AUD.
Argent Biopharma Ltd Long-term Investment Intensity by Year (2018–2024)
Argent Biopharma Ltd long-term investment intensity by year from 2018 to 2024. The table below presents the year-by-year Long-term Investment Intensity for Argent Biopharma Ltd from 2018 to 2024, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Argent Biopharma Ltd total assets.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 12.3% | AU$1.33 Million | AU$10.79 Million | ▲ +11.5 pp |
| 2022 | 0.8% | AU$155.97K | AU$18.56 Million | ▼ -7.7 pp |
| 2020 | 8.5% | AU$673.74K | AU$7.93 Million | ▼ -12.8 pp |
| 2019 | 21.3% | AU$2.77 Million | AU$13.00 Million | ▲ +21.0 pp |
| 2018 | 0.4% | AU$72.86K | AU$19.99 Million | — |